When is INSP's latest earnings report released?
The most recent financial report for Inspire medical systems, inc. (INSP) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating INSP's short-term business performance and financial health. For the latest updates on INSP's earnings releases, visit this page regularly.
Where does INSP fall in the P/E River chart?
According to historical valuation range analysis, Inspire medical systems, inc. (INSP)'s current price-to-earnings (P/E) ratio is 11.75, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of INSP?
According to the latest financial report, Inspire medical systems, inc. (INSP) reported an Operating Profit of 46.11M with an Operating Margin of 17.14% this period, representing a growth of 44.62% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is INSP's revenue growth?
In the latest financial report, Inspire medical systems, inc. (INSP) announced revenue of 269.08M, with a Year-Over-Year growth rate of 12.25%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much cash does INSP have?
At the end of the period, Inspire medical systems, inc. (INSP) held Total Cash and Cash Equivalents of 104.81M, accounting for 0.12 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does INSP go with three margins increasing?
In the latest report, Inspire medical systems, inc. (INSP) achieved the “three margins increasing” benchmark, with a gross margin of 86.6%%, operating margin of 17.14%%, and net margin of 50.6%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess INSP's profit trajectory and future growth potential.
Is INSP's EPS continuing to grow?
According to the past four quarterly reports, Inspire medical systems, inc. (INSP)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 4.63. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of INSP?
Inspire medical systems, inc. (INSP)'s Free Cash Flow (FCF) for the period is 41.81M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 32.73% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of INSP?
The latest valuation data shows Inspire medical systems, inc. (INSP) has a Price-To-Earnings (PE) ratio of 11.75 and a Price/Earnings-To-Growth (PEG) ratio of 0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.
